The is an online model for clinicians to predict late distant metastasis for women with ER-positive breast cancer who are recurrence-free 5 years after endocrine therapy. Patients should always seek advice from their doctors when interpreting the results from this tool.
Read more

CTS5 Score 5–10 Year Risk Likelihood of Extended Endocrine Benefit